The metabolic effects of IGF-II via IR-A may support the increased energy demands of the tumor, potentially via the ability of IR-A to act as a co-transporter with GLUT1 or GLUT2 to enhance basal glucose uptake [151,161]. Here, IGF2 is linked to neoplasm.